Covid update

Company profile

BioConnection is a contract services and manufacturing organization for the development and manufacturing of injectable (bio)pharmaceutical products. From our FDA approved manufacturing site in Oss, the Netherlands we service our customers. Besides our own facility we have access to various partners across Europe to enable unmatched flexibility in solutions, capacity and capability. The cornerstones of our CMC services are: Drug Product development, Fill and Finish, Freeze-drying and Clinical Trial Material services.

Your invention from lab to clinic or market

We have the means and expertise to bring your invention from the lab bench to the clinic and/or to the market. Due to our unique setup, our leading manufacturing site in Oss and best-in-class European network of development and manufacturing partners we are able to provide you with tailor-made solutions and unmatched flexibility. Our approach ensures a seamless development and manufacturing chain for your product.

In 2021, we expanded our capacity with a commercial production line. You can read the history of the construction of our new production line in this archive.

Our mission

As a company, we have a mission we want to share with the world. Having an impact on the biopharmaceutical industry is important for us. Read our specific goals here.

Inspired by BioConnection as a company?

Let’s get in touch to see what we can do for you. Numerous biopharmaceutical companies already had great experiences with BioConnection.

Take a look around

Though we are young, flexible and innovative company, we also have years of experience and we own facilities you’d expect to see in a larger company. In this video we show you around in our state-of-the-art-GMP manufacturing facility, giving you an idea of how we can bring value to your project.

Summary of our services

Drug product development

  • Formulation development
  • Process and analytical development & validation
  • Lyo-cycle development and/or optimization
  • Transfer and scale-up to clinic
  • Transfer and scale-up to market

Freeze drying

  • Shelf areas ranging from 3 m² up to 10 m²

Clinical trial material services

  • Labeling
  • Clinical trial packaging
  • QP release
  • Storage

Fill and Finish

  • Batch sizes: from 1 unit up to 150,000 units per batch
  • Clinical and commercial scale
  • Automated fill and hand fill
  • Aseptic filling
  • Vials: from 2 RDIN up to 50 RDIN
  • Syringes: from 0.5 ml up to 10 ml
  • Other primary packs: via handfill
  • Terminal sterilization

Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM ( This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project ( is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via

The BioConnection Management Team.

You have Successfully Subscribed!